186 related articles for article (PubMed ID: 25847324)
1. The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus.
Cayir A; Ugan RA; Albayrak A; Kose D; Akpinar E; Cayir Y; Atmaca HT; Bayraktutan Z; Kara M
J Endocrinol Invest; 2015 Sep; 38(9):987-98. PubMed ID: 25847324
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition.
Demirci E; Ferah I; Gundogdu C; Ozkanlar S; Baygutalp NK; Bayir Y; Calik M; Ayaz G
Drug Res (Stuttg); 2015 May; 65(5):272-80. PubMed ID: 24918345
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelin receptors and relationship with nitric oxide synthase in impaired erectile response in diabetic rats.
Alkan E; Ugan RA; Basar MM; Halici Z; Karakus E; Balbay MD; Un H
Andrologia; 2017 Mar; 49(2):. PubMed ID: 27145076
[TBL] [Abstract][Full Text] [Related]
4. Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.
Gupta SK; Saxena A; Singh U; Arya DS
Mol Cell Biochem; 2005 Jul; 275(1-2):67-74. PubMed ID: 16335785
[TBL] [Abstract][Full Text] [Related]
5. Bosentan ameliorates the expression of fibrotic related growth factors and collagen-1 in diabetic mice.
Yang B; Li M; Shi ZG; Feng QZ
Anadolu Kardiyol Derg; 2012 Dec; 12(8):621-7. PubMed ID: 22968296
[TBL] [Abstract][Full Text] [Related]
6. Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control.
Abdelsaid M; Kaczmarek J; Coucha M; Ergul A
Life Sci; 2014 Nov; 118(2):268-73. PubMed ID: 24447630
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
Singh G; Sharma B; Jaggi AS; Singh N
Pharmacol Biochem Behav; 2014 Sep; 124():27-35. PubMed ID: 24836182
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats.
Yayla M; Halici Z; Unal B; Bayir Y; Akpinar E; Gocer F
Eur J Pharmacol; 2014 Mar; 726():87-95. PubMed ID: 24462570
[TBL] [Abstract][Full Text] [Related]
9. Does bosentan protect diabetic brain alterations in rats? The role of endothelin-1 in the diabetic brain.
Demir R; Cadirci E; Akpinar E; Cayir Y; Atmaca HT; Un H; Kunak CS; Yayla M; Bayraktutan Z; Demir I
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):236-43. PubMed ID: 25200216
[TBL] [Abstract][Full Text] [Related]
10. Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.
Serafim KG; Navarro SA; Zarpelon AC; Pinho-Ribeiro FA; Fattori V; Cunha TM; Alves-Filho JC; Cunha FQ; Casagrande R; Verri WA
Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1211-21. PubMed ID: 26246053
[TBL] [Abstract][Full Text] [Related]
11. Effects of diabetes on cytokines and oxidative organ injury in a rat model of sepsis.
Uyanik MH; Albayrak A; Odabasoglu F; Karakus E; Ozden K; Polat B; Yayla M; Karamese M; Albayrak A; Yazgi H
Cell Mol Biol (Noisy-le-grand); 2012 Feb; 58 Suppl():OL1623-31. PubMed ID: 22340705
[TBL] [Abstract][Full Text] [Related]
12. Blockade of endothelin receptors with bosentan limits ischaemia/reperfusion-induced injury in rat ovaries.
Sengul O; Ferah I; Polat B; Halici Z; Bayir Y; Yilmaz M; Kilic N; Keles ON
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):458-63. PubMed ID: 23880599
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced acute lung injury is aggravated in streptozotocin diabetic mice.
Wang LM; Zhong NZ; Liu SJ; Zhu XY; Liu YJ
Exp Lung Res; 2015 Apr; 41(3):146-54. PubMed ID: 25514628
[TBL] [Abstract][Full Text] [Related]
14. Chronic endothelin antagonism restores cerebrovascular function in diabetes.
Dumont AS; Dumont RJ; McNeill JH; Kassell NF; Sutherland GR; Verma S
Neurosurgery; 2003 Mar; 52(3):653-60; discussion 659-60. PubMed ID: 12590691
[TBL] [Abstract][Full Text] [Related]
15. Long-term endothelin receptor blockade improves cardiovascular function in diabetes.
Verma S; Arikawa E; McNeill JH
Am J Hypertens; 2001 Jul; 14(7 Pt 1):679-87. PubMed ID: 11465653
[TBL] [Abstract][Full Text] [Related]
16. Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes.
Abdelsaid M; Ma H; Coucha M; Ergul A
Life Sci; 2014 Nov; 118(2):263-7. PubMed ID: 24434796
[TBL] [Abstract][Full Text] [Related]
17. Using bosentan to treat paraquat poisoning-induced acute lung injury in rats.
Zhang Z; Jian X; Zhang W; Wang J; Zhou Q
PLoS One; 2013; 8(10):e75943. PubMed ID: 24155875
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Bosentan's Effects on Pulmonary Contusion Created by Blunt Thoracic Trauma in Rats.
Gercel G; Aksu B; Ozkanli S; Uzun H; Aksu F; Ozatman E; Durakbaşa ÇU
Eur J Pediatr Surg; 2020 Feb; 30(1):71-78. PubMed ID: 31600800
[TBL] [Abstract][Full Text] [Related]
19. Nephroprotective effect of bosentan in diabetic rats.
Cosenzi A; Bernobich E; Trevisan R; Milutinovic N; Borri A; Bellini G
J Cardiovasc Pharmacol; 2003 Dec; 42(6):752-6. PubMed ID: 14639097
[TBL] [Abstract][Full Text] [Related]
20. Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms.
Jiang J; Yuen V; Xiang H; McNeill JH
Mol Cell Biochem; 2006 Jan; 282(1-2):177-85. PubMed ID: 16317525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
